<DOC>
	<DOCNO>NCT00419991</DOCNO>
	<brief_summary>Tigecycline develop agent overcomes tetracycline-resistance mechanism provide activity emerge multi-drug resistant pathogen . The purpose protocol determine linkage time related clinical measure infection response time bacterial eradication patient intravascular catheter infection cause Staphylococcus epidermidis coagulase negative staphylococci .</brief_summary>
	<brief_title>Open Label Non-comparative Clinical Trial Tigecycline Patients With Catheter Infection</brief_title>
	<detailed_description>Tigecycline , glycylcycline antibiotic analog tetracycline minocycline , demonstrate broad spectrum antibacterial activity inhibit multiply resistant gram-positive , gram-negative , anaerobic , `` atypical '' bacteria . It develop agent overcomes tetracycline-resistance mechanism provide activity emerge multi-drug resistant pathogen . These attribute may provide clinician valuable therapeutic alternative . The purpose protocol determine linkage time related clinical measure infection response time bacterial eradication patient intravascular catheter infection cause Staphylococcus epidermidis coagulase negative staphylococci . The study conduct two phase . The first treat patient removal catheter time treatment , second treat patient catheter remain situ tigecycline treatment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Male female patient , 1885 year age weight &gt; 45 kilogram . Patients intravascular catheter blood culture positive grampositive cocci cluster . Patients subsequently exclude study analysis culturepositive infection S. epidermidis coagulase negative staphylococci , expect susceptible tigecycline . Patients bacteremia culture daily site investigator . Patients fail available antibiotic therapy may enrol positive blood culture organism susceptibility tigecycline . Patients culture daily site investigator . Intravascular catheter infection know cause bacteria coagulase negative staphylococci , example , Staphylococcus aureus . Any patient receive 24 hr vancomycin . Any patient receive antibiotic active S. epidermidis vancomycin . Patients moribund expect survival le 2 week . Patients neutropenic ( ANC &lt; 500 ) time bacteremia Patients designate `` Do Not Resuscitate '' , unless anticipate within reasonable degree medical certainty achieve benefit tigecycline therapy . Known suspected hypersensitivity tigecycline , tetracycline , compound related class antibacterial agent . Pregnant woman nurse mother . Female patient childbearing potential agree use medically acceptable method contraception throughout duration study least 1 month last dose tigecycline . Patients suspect proven endocarditis osteomyelitis Patients suspect proven mycobacterial infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Tigecycline</keyword>
	<keyword>Staphylococcal Infections</keyword>
	<keyword>Catheter</keyword>
</DOC>